Iván Maray

ORCID: 0000-0002-8204-5178
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Colorectal and Anal Carcinomas
  • Antimicrobial Resistance in Staphylococcus
  • Head and Neck Cancer Studies
  • Cancer Treatment and Pharmacology
  • Eosinophilic Esophagitis
  • Platelet Disorders and Treatments
  • Cancer Diagnosis and Treatment
  • Lymphadenopathy Diagnosis and Analysis
  • Eosinophilic Disorders and Syndromes
  • Soft tissue tumors and treatment
  • Clostridium difficile and Clostridium perfringens research
  • Complement system in diseases
  • Artificial Intelligence in Healthcare
  • Colorectal Cancer Treatments and Studies
  • Antibiotics Pharmacokinetics and Efficacy
  • Bacterial Identification and Susceptibility Testing
  • Protein Degradation and Inhibitors
  • Nosocomial Infections in ICU
  • Multiple Myeloma Research and Treatments
  • Adenosine and Purinergic Signaling
  • Advanced Breast Cancer Therapies
  • Acute Kidney Injury Research
  • Inflammatory Bowel Disease
  • Lung Cancer Treatments and Mutations
  • IL-33, ST2, and ILC Pathways

Instituto de Investigación Sanitaria del Principado de Asturias
2024

Central University Hospital of Asturias
2021-2024

Organización Nacional de Trasplantes
2023

TIE Kinetix (Germany)
2023

Hospital Universitario 12 De Octubre
2023

Ministry of Health
2022

Gobierno del Principado de Asturias
2022

Background. Kikuchi-Fujimoto Disease (KFD) or histiocytic necrotizing lymphadenitys is a rare disorder characterized by subacute regional lymphadenopathy. It usually presented as painful cervical nodes and associated with fever, headache, night sweats, nausea, vomiting sore throat. Etiology of KFD still unclear, two theories have been proposed: infections autoimmune origin. Due to recent reports related COVID-19 vaccination, the novelty mechanism these vaccines immunomodulated role both...

10.23822/eurannaci.1764-1489.273 article EN European Annals of Allergy and Clinical Immunology 2022-11-15

Background/Aim: This study aimed to assess the effectiveness and safety of nivolumab versus cetuximab in patients with Recurrent/Metastatic Squamous Cell Carcinoma Head Neck (R/M HNSCC), as well analyze possible prognostic factors for response treatment nivolumab. Patients Methods: We conducted an observational, retrospective, descriptive R/M HNSCC who initiated or monotherapy two periods equivalent duration. Overall efficacy was measured terms progression-free survival (PFS) overall (OS)....

10.21873/anticanres.16320 article EN Anticancer Research 2023-03-27

The objective was to evaluate the incidence of nephrotoxicity related vancomycin and other anti-MRSA antibiotics (linezolid daptomycin). Patients receiving any these drugs between July 2014 December 2020 at a tertiary hospital were included. Renal failure evaluated using acute renal injury (AKIN) system. Univariate analysis conducted on 5806 patients who Among them, 1023 (17.62%) developed failure. damage 14.74% (496/3365) for vancomycin, 19.13% (367/1918) linezolid, 30.59% (160/523)...

10.3390/futurepharmacol4010004 article EN cc-by Future Pharmacology 2024-01-09

<h3>Background and Importance</h3> Clostridioides difficile infection (CDI) is the main cause of infectious diarrhoea in hospital setting. <h3>Aim Objectives</h3> The aim this study to analyse use effectiveness fidaxomicin CDI. <h3>Material Methods</h3> An observational, descriptive retrospective was conducted patients treated with between April 2018-August 2023. Variables, collected through electronic medical record, were: sex, age, patient location, immunosuppression, severity type...

10.1136/ejhpharm-2024-eahp.226 article EN Section 4: Clinical pharmacy services 2024-03-01

Lenalidomide remains an effective drug for multiple myeloma, but it is often associated with adverse events and requires dose adjustments. The objective of this study was to propose a model predicting whether patient would require adjustment.

10.1177/10781552231200795 article EN Journal of Oncology Pharmacy Practice 2023-09-06

Metastatic breast cancer (MBC) is incurable. Systemic therapy the standard treatment; however, an optimal sequence of chemotherapy has not been established.Evaluating effectiveness and safety eribulin in MBC treatment comparing results obtained with published literature.Observational, descriptive retrospective study patients treated from 01/12/2015 to 30/10/2021. Effectiveness was analysed using Kaplan-Meier-survival-curves, for overall number stratified by line. Safety measured according...

10.3233/bd-230031 article EN Breast Disease 2023-12-05

Aim Assess the effectiveness and safety of nivolumab versus cetuximab in patients with R/M HNSCC, as well to analyze possible prognostic factors for response treatment nivolumab. Methods We conducted an observational, retrospective, descriptive study HNSCC who initiated or monotherapy two periods equivalent duration. Overall efficacy was measured progression-free survival (PFS) overall (OS); evaluated using CTCAE (Common Terminology Criteria Adverse Events) classification version 5.0...

10.22541/au.166124890.02774033/v1 preprint EN Authorea (Authorea) 2022-08-23

Aim Assess the effectiveness and safety of nivolumab versus cetuximab in patients with R/M HNSCC, as well to analyze possible prognostic factors for response treatment nivolumab. Methods We conducted an observational, retrospective, descriptive study HNSCC who initiated or monotherapy two periods equivalent duration. Overall efficacy was measured progression-free survival (PFS) overall (OS); evaluated using CTCAE (Common Terminology Criteria Adverse Events) classification version 5.0...

10.22541/au.166124890.02774033/v2 preprint EN Authorea (Authorea) 2022-08-23
Coming Soon ...